COMMONWEALTH EQUITY SERVICES, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$901
-5.8%
34,663
+3.7%
0.00%
-50.0%
Q1 2024$956
-7.9%
33,413
-1.5%
0.00%0.0%
Q4 2023$1,038
+12.8%
33,928
-0.9%
0.00%0.0%
Q3 2023$920
-25.0%
34,242
-0.4%
0.00%0.0%
Q2 2023$1,226
+41.4%
34,390
+0.6%
0.00%0.0%
Q1 2023$867
+241.3%
34,172
+444.9%
0.00%
+100.0%
Q4 2022$254
-99.9%
6,271
-3.7%
0.00%0.0%
Q3 2022$215,000
-9.7%
6,513
-3.7%
0.00%0.0%
Q2 2022$238,000
-8.1%
6,764
+19.8%
0.00%0.0%
Q1 2022$259,000
-37.0%
5,648
-9.0%
0.00%0.0%
Q4 2021$411,000
+2.2%
6,209
-3.7%
0.00%0.0%
Q3 2021$402,000
-55.6%
6,449
-41.0%
0.00%
-50.0%
Q2 2021$905,000
+11.9%
10,934
-10.4%
0.00%0.0%
Q1 2021$809,000
-13.8%
12,203
-0.3%
0.00%
-33.3%
Q4 2020$939,000
+82.0%
12,238
+2.0%
0.00%
+50.0%
Q3 2020$516,0000.0%12,002
+0.3%
0.00%0.0%
Q2 2020$516,000
+54.0%
11,968
+2.6%
0.00%0.0%
Q1 2020$335,000
-61.5%
11,665
-15.1%
0.00%
-33.3%
Q4 2019$871,000
+190.3%
13,740
+29.0%
0.00%
+200.0%
Q3 2019$300,000
+17.6%
10,650
+10.4%
0.00%0.0%
Q2 2019$255,000
+29.4%
9,650
-10.5%
0.00%0.0%
Q1 2019$197,00010,7850.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2021
NameSharesValueWeighting ↓
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$93,815,00051.06%
Aquilo Capital Management, LLC 436,514$12,559,0004.90%
Vivo Capital, LLC 768,674$22,115,0002.00%
ACUTA CAPITAL PARTNERS, LLC 109,700$3,156,0001.53%
Prosight Management, LP 104,737$3,013,0001.41%
Capital Impact Advisors, LLC 84,537$2,432,0001.02%
Artal Group S.A. 600,000$17,262,0000.73%
HUSSMAN STRATEGIC ADVISORS, INC. 62,000$1,784,0000.48%
Quantitative Investment Management, LLC 150,401$4,327,0000.47%
OAK RIDGE INVESTMENTS LLC 131,502$3,784,0000.39%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders